VR Logo

Cadila Healthcare Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: Pankaj R Patel

Managing Director: Sharvil P Patel

Group: Cadila

Listing: NSE: CADILAHC, BSE: 532321

Headquarters: Ahmedabad, Gujarat

Website: www.zyduscadila.com

Key Facts

Market cap: R 36,470.83 Cr

Revenue (TTM): R 14,253.10 Cr

Earnings (TTM): R 1,175.60 Cr

Cash: R 879.20 Cr

Total Debt: R 7,899.40 Cr

Promoters' ownership: 74.88%

Liquidity: High

52 Week range: R 202.00 - 383.65

Face value: R1.00

Shares outstanding: 1,02,37,42,600

10 Years Aggregate:

  • CFO: 11,395.70 Cr
  • EBITDA: 17,004.90 Cr
  • Net Profit: 11,663.00 Cr

Stock Performance

Time Period Cadila Healthcare S&P BSE Sensex S&P BSE Healthcare
YTD40.15-11.2923.40
1 month-3.476.851.46
3 months1.5117.4413.86
1 Year56.11-5.0929.91
3 Years-11.804.884.43
5 Years-1.205.75-0.57
10 Years10.537.4411.15
As on 10-Jul-2020
Year Cadila Healthcare S&P BSE Sensex S&P BSE Healthcare
2019-27.3514.38-3.55
2018-19.525.87-5.89
201721.5527.910.49
20167.201.95-12.88
20151.60-5.0315.06
2014100.2829.8947.43
2013-9.908.9822.55